Bone and Mineral Diagnostic Testing Market Size Forecasted to Reach $1.42 Billion by 2029 with 5.6% CAGR

The Business Research Company’s report on the Bone and Mineral Diagnostic Testing Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.

How are market drivers shaping the future growth trajectory of the bone and mineral diagnostic testing industry?

An increase in the incidence of bone-related diseases is expected to propel the growth of the bone and mineral diagnostic testing market going forward. Bone-related diseases are ailments that alter the strength or flexibility of bones, making them weaker and more prone to fractures, and can cause symptoms such as bone pain, trouble moving, and an increased risk of bone fractures. Bone and mineral diagnostic tests, such as bone density tests, can assist in preventing bone diseases by identifying low bone density before osteoporosis grows, forecasting the risk of future fractures, and tracking the efficacy of ongoing osteoporosis treatment. The increasing incidence of bone-related diseases, coupled with growing awareness and technological advancements, is expected to fuel the growth of the bone and mineral diagnostic testing market. For instance, In May 2022, according to The National Center for Biotechnology Information (NCBI), a US-based government organization, the primary complication of osteoporosis is fracture, with projections suggesting a 310% increase in global hip fractures among men and a 240% increase among women by 2050. Therefore, an increase in the incidence of bone-related diseases will drive the bone and mineral diagnostic testing market.

Access Your Free Sample of the Global Bone and Mineral Diagnostic Testing Market Report – Get Insights Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=10731&type=smp

What is the estimated market size of the bone and mineral diagnostic testing sector by 2029, based on current forecasts?

The bone and mineral diagnostic testing market size has grown steadily in recent years. It will grow from$1.09 billion in 2024 to $1.14 billion in 2025 at a compound annual growth rate (CAGR) of 4.9%. The growth in the historic period can be attributed to aging population demands, prevalence of osteoporosis, awareness and education initiatives, clinical need for monitoring, fracture risk assessment

The bone and mineral diagnostic testing market size is expected to see strong growth in the next few years. It will grow to “$1.42 billion in 2029 at a compound annual growth rate (CAGR) of 5.6%. The growth in the forecast period can be attributed to advancements in diagnostic technologies, increasing incidence of metabolic bone diseases, growing focus on preventive healthcare, integration with personalized medicine approaches. Major trends in the forecast period include integration of biochemical markers, telemedicine and remote monitoring, expansion of home-based testing kits, collaborations for research and innovation, emphasis on comprehensive diagnostic panels.

Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=10731&type=smp

#Who are the top players in the bone and mineral diagnostic testing market?

Major companies operating in the bone and mineral diagnostic testing market include Abbott Laboratories, bioMérieux SA, DiaSorin S.p.A., QuidelOrtho Corporation, Siemens Healthineers AG, F. Hoffmann-La Roche AG, GE HealthCare Technologies Inc., Hologic Inc., Beammed Ltd., Swissray International Inc., Osteosys Co. Ltd., Diagnostic Medical System SA, Medonica Co. Ltd., Epitope Diagnostics Inc., Alere Inc., Beckman Coulter Inc., Bio Rad Laboratories Inc., Calbiotech Inc., Roche Diagnostics India Pvt. Ltd., Ortho-Clinical Diagnostics, Enzo Life Sciences lnc., Medtronic plc, Thermo Fisher Scientific lnc., Sysmex Corporation, EKF Diagnostics, Bruker Corporation, Esaote SpA, Hitachi Ltd., Koninklijke Philips N.V., Mindray Medical International Limited, PerkinElmer Inc., Shimadzu Corporation, Toshiba Medical Systems Corporation, Waters Corporation, Danaher Corporation, Merck KGaA

#What are the major trends in the bone and mineral diagnostic testing market?

Technological advancements are a key trend gaining popularity in the bone and mineral diagnostic testing market. Companies operating in the bone and mineral diagnostic testing market are adopting new technologies to sustain their position in the market. In May 2022, GE HealthCare Technologies Inc., a US-based medical technology company, developed an innovative MRI technique that uses novel pulse sequences such as zero echo time (ZTE) to see tendons, ligaments, calcium deposits, and cortical bone structures. This novel advancement in MR bone imaging gives computed tomography (CT)-like image contrast in 3D isotropic resolution while exposing the patient to no ionizing radiation. It is currently used to obtain morphological information regarding cortical bone structure in anatomical structures such as the shoulder, hip, skull, foot/ankle, and spine. Its potential is especially appealing when longitudinally CTs are required, mainly if low-dose CTs are unavailable.

Which geography holds the highest bone and mineral diagnostic testing market share?

North America was the largest region in the bone and mineral diagnostic testing market in 2024. The regions covered in the bone and mineral diagnostic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Order Your Report Now For Swift Delivery

https://www.thebusinessresearchcompany.com/report/bone-and-mineral-diagnostic-testing-global-market-report

How do different segments contribute to the overall expansion of the bone and mineral diagnostic testing market?

The bone and mineral diagnostic testing market covered in this report is segmented –

1) By Product: Assays Or Consumables, Instruments

2) By Test Type: Enzyme-Linked Immunosorbent Assay (ELISA), Clinical Laboratory Improvement Amendments (CLIA), Other Test Types

3) By Application: Vitamin D Testing, Bone Metabolism

Subsegments:

1) By Assays Or Consumables: Bone Turnover Markers Assays, Vitamin D Assays, Calcium And Phosphate Assays, Sample Collection Kits, Reagents And Standards

2) By Instruments: Bone Densitometers, X-Ray Machines, Ultrasound Devices, MRI Machines, Other Diagnostic Instruments

Purchase The Exclusive Report Now To Unlock Valuable Market Insights:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10731

How is the bone and mineral diagnostic testing market defined?

A bone and mineral diagnostic test is a medical treatment that determines the quantity of calcium and other minerals in a section of bone. This test is used to detect bone loss and osteoporosis, monitor osteoporosis therapy, and assess the risk of fractures.

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.

Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Contact Us:

The Business Research Company

https://thebusinessresearchcompany.com/

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: [email protected]

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Leave a Reply

Your email address will not be published. Required fields are marked *